Global Diltiazem Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Diltiazem Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ918319 | No. of Pages: 128 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Sep-2021
Executive Summary

According to GRD Survey data, the global Diltiazem market was valued at  million US$ in 2020 and is expected to  million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Diltiazem market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Diltiazem in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Tablet

    Capsule

    Injection

Market Snapshot, By Application
    Angina

    Hypertension

Market Snapshot, By Region:
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        South Africa
        Israel
        Turkey
        Saudi Arabia

Main Market Players Analyzed in this report, including:
    Zydus Pharmaceuticals

    Teva

    Sun Pharma

    Sandoz

    Pfizer

    Par Pharmaceutical

    Mylan

    Hikma Pharmaceuticals

    Bausch Health

    Athenex

    Akorn


The study objectives of this report are:
    To study and analyze the global Diltiazem market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Diltiazem market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Diltiazem manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Diltiazem market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Diltiazem submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Diltiazem are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Diltiazem Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Diltiazem Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Diltiazem

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Diltiazem Sales Channel and Distributors Analysis
        3.3.1 Diltiazem Sales Channel
        3.3.2 Diltiazem Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Angina

        3.4.2 Major Buyers in Hypertension
    3.5 Diltiazem Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Diltiazem Type Introduction
        4.1.1 Tablet

        4.1.2 Capsule

        4.1.3 Injection
    4.2 Global Diltiazem Sales by Type 2016-2021
    4.3 Global Diltiazem Revenue by Type 2016-2021
    4.4 Global Diltiazem Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Diltiazem Type Introduction
        5.1.1 Angina

        5.1.2 Hypertension
    5.2 Global Diltiazem Sales by Application 2016-2021
    5.3 Global Diltiazem Revenue by Application 2016-2021
    5.4 Global Diltiazem Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Diltiazem Market by Region
        6.1.1 Global Diltiazem Sales by Regions
        6.1.2 Global Diltiazem Revenue by Regions
    6.2 North America Diltiazem Market 2016-2021
    6.3 Europe Diltiazem Market 2016-2021
    6.4 Asia Pacific Diltiazem Market 2016-2021
    6.5 South America Diltiazem Market 2016-2021
    6.6 Middle East and Africa Diltiazem Market 2016-2021

7 North America
    7.1 North America Diltiazem Market by Country 2016-2021
        7.1.1 North America Diltiazem Sales by Country
        7.1.2 North America Diltiazem Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Diltiazem Market by Country 2016-2021
        8.1.1 Europe Diltiazem Sales by Country
        8.1.2 Europe Diltiazem Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Diltiazem Market by Country 2016-2021
        9.1.1 Asia Pacific Diltiazem Sales by Country
        9.1.2 Asia Pacific Diltiazem Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Diltiazem Market by Country 2016-2021
        10.1.1 South America Diltiazem Sales by Country
        10.1.2 South America Diltiazem Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Diltiazem Market by Country 2016-2021
        11.1.1 Middle East and Africa Diltiazem Sales by Country
        11.1.2 Middle East and Africa Diltiazem Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Zydus Pharmaceuticals

        12.1.1 Zydus Pharmaceuticals
 Company Information
        12.1.2 Zydus Pharmaceuticals
 Diltiazem Product Portfolio, Specification and Application
        12.1.3 Zydus Pharmaceuticals
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Zydus Pharmaceuticals
 Key Development
    12.2 Teva

        12.2.1 Teva
 Company Information
        12.2.2 Teva
 Diltiazem Product Portfolio, Specification and Application
        12.2.3 Teva
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Teva
 Key Development
    12.3 Sun Pharma

        12.3.1 Sun Pharma
 Company Information
        12.3.2 Sun Pharma
 Diltiazem Product Portfolio, Specification and Application
        12.3.3 Sun Pharma
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Sun Pharma
 Key Development
    12.4 Sandoz

        12.4.1 Sandoz
 Company Information
        12.4.2 Sandoz
 Diltiazem Product Portfolio, Specification and Application
        12.4.3 Sandoz
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Sandoz
 Key Development
    12.5 Pfizer

        12.5.1 Pfizer
 Company Information
        12.5.2 Pfizer
 Diltiazem Product Portfolio, Specification and Application
        12.5.3 Pfizer
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Pfizer
 Key Development
    12.6 Par Pharmaceutical

        12.6.1 Par Pharmaceutical
 Company Information
        12.6.2 Par Pharmaceutical
 Diltiazem Product Portfolio, Specification and Application
        12.6.3 Par Pharmaceutical
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Par Pharmaceutical
 Key Development
    12.7 Mylan

        12.7.1 Mylan
 Company Information
        12.7.2 Mylan
 Diltiazem Product Portfolio, Specification and Application
        12.7.3 Mylan
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Par Pharmaceutical
 Key Development
    12.9 Bausch Health

        12.9.1 Bausch Health
 Company Information
        12.9.2 Bausch Health
 Diltiazem Product Portfolio, Specification and Application
        12.9.3 Bausch Health
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.9.4 Bausch Health
 Key Development
    12.8 Hikma Pharmaceuticals

        12.8.1 Hikma Pharmaceuticals
 Company Information
        12.8.2 Hikma Pharmaceuticals
 Diltiazem Product Portfolio, Specification and Application
        12.8.3 Hikma Pharmaceuticals
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Hikma Pharmaceuticals
 Key Development
    12.11 Akorn

        12.11.1 Akorn
 Company Information
        12.11.2 Akorn
 Diltiazem Product Portfolio, Specification and Application
        12.11.3 Akorn
 Diltiazem Sales, Price, Revenue and Gross Margin (2019-2021)
        12.11.4 Akorn
 Key Development

13 Global Diltiazem Market Forecast by Region by Type and by Application
    13.1 Global Diltiazem Sales, Revenue Forecast 2022-2027
    13.2 Global Diltiazem Forecast by Regions
        13.2.1 Global Diltiazem Sales Forecast by Region 2022-2027
        13.2.2 Global Diltiazem Revenue Forecast by Region 2022-2027
    13.3 Global Diltiazem Forecast by Type
        13.3.1 Global Diltiazem Sales Forecast by Type 2022-2027
        13.3.2 Global Diltiazem Revenue Forecast by Type 2022-2027
        13.3.3 Global Diltiazem Price Forecast by Type 2022-2027
    13.4 Global Diltiazem Forecast by Application
        13.4.1 Global Diltiazem Sales Forecast by Application 2022-2027
        13.4.2 Global Diltiazem Revenue Forecast by Application 2022-2027
        13.4.3 Global Diltiazem Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com